{ "items": [ "\n\n
\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n25 March 2022
\n \n \n \nThe \u00a33.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
\n \n\n \n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n7 March 2022
\n \n \n \nResearchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
\n \n\n \n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n7 March 2022
\n \n \n \nThe Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly \u00a3161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n15 February 2022
\n \n \n \nProfessor Keith Channon has been appointed as the next Head of the Radcliffe Department of Medicine (RDM).
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n10 January 2022
\n \n \n \nMatthew Rushworth replaces Kia Nobre as interim Head of the Department of Experimental Psychology
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n7 January 2022
\n \n \n \nHuman-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
\n \n\n \n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n19 November 2021
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n3 November 2021
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n3 November 2021
\n \n \n \nMembers of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n1 November 2021
\n \n \n \nThe recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.
\n \n\n \n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n27 October 2021
\n \n \n \nThe University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
\n \n\n \n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n27 October 2021
\n \n \n \nA major new $9 million project funded by the Aligning Science Across Parkinson\u2019s (ASAP) initiative will map the original circuits vulnerable to Parkinson\u2019s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
\n \n\n \n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n25 October 2021
\n \n \n \nResearchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in human consciousness.
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n10 September 2021
\n \n \n \nThe Department of Experimental Psychology has recruited two senior researchers.
\n \n\n \n \n\n \n\n \n \n \n \n Awards and Honours\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n16 August 2021
\n \n \n \nThe Large Lecture Theatre in the Sherrington Building is being renamed the Blakemore Lecture Theatre in tribute to the longest serving Waynflete Professor of Physiology Sir Colin Blakemore FRS following a prestigious Festschrift event held in Professor Blakemore's honour.
\n \n\n \n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n5 August 2021
\n \n \n \nMore research is needed to improve the treatment of brain diseases such as depression, Alzheimer\u2019s or ADHD. A widely held view within the scientific community is that this cannot be done without ethically conducted animal research.
\n \n\n \n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n24 June 2021
\n \n \n \nAn Oxford project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) is one of 38 projects support by the second wave of the NHS AI Lab's AI in Health and Care Award.
\n \n\n \n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n11 June 2021
\n \n \n \nProfessor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n23 April 2021
\n \n \n \nThe new partnership between Oxford Health NHS Foundation Trust, the University of Oxford, the University of Toronto, and the Centre for Addiction and Mental Health (CAMH) in Toronto, will enable the development of key structures to facilitate collaboration.
\n \n\n \n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n26 March 2021
\n \n \n \nGround-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.
\n \n\n \n \n